Case number 3:19-cv-19345
NOVARTIS PHARMACEUTICALS CORPORATION v. MACLEODS PHARMACEUTICALS LTD. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 19, 2019 | 8 | Order of Dismissal (2) Docket Text: ORDER OF DISMISSAL without prejudice. Signed by Judge Mitchell Goldberg (EDPA) on 11/19/2019. (jmh) |
| Nov 15, 2019 | 7 | Letter (1) |
| Nov 15, 2019 | 7 | Text of Proposed Order (2) |
| Nov 15, 2019 | 7 | Main Document (1) Docket Text: Letter from Plaintiff to Hon. Mitchell Goldberg, U.S.D.J.. (Attachments: # (1) Text of Proposed Order)(BETZ, CYNTHIA) |
| Nov 4, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Mitchell Goldberg (EDPA). Chief Judge Freda L. Wolfson no longer assigned to the case. (jjc, ) |
| Nov 4, 2019 | 6 | USCA Order (Does NOT Term Appeal) (1) Docket Text: ORDER of USCA: Designation of District Judge for Service in Another District Within the Circuit. The Honorable Mitchell S. Goldberg of the USDC for the Eastern District of Pennsylvania is designated and assigned as the presiding Judge in this matter. (jjc) |
| Oct 25, 2019 | N/A | Add and Terminate Judges (0) Docket Text: Chief Judge Freda L. Wolfson and Magistrate Judge Douglas E. Arpert added. (abr) |
| Oct 25, 2019 | N/A | QC - Disclosure Statement filed as an Attachment (0) Docket Text:CLERK'S QUALITY CONTROL MESSAGE - The Corporate Disclosure Statement filed by JOHN FLAHERTY on 10/25/2019 was submitted with a Corporate Disclosure Statement as an attachment. PLEASE RESUBMIT the Corporate Disclosure Statement USING the event CORPORATE DISCLOSURE STATEMENT found under Other Filings -> Other Documents. (abr) |
| Oct 25, 2019 | 1 | Complaint (13) |
| Oct 25, 2019 | 1 | Exhibit A (11) |
| Oct 25, 2019 | 1 | Exhibit B (21) |
| Oct 25, 2019 | 1 | Exhibit C (20) |
| Oct 25, 2019 | 1 | Statement of Corporate Disclosures (2) |
| Oct 25, 2019 | 1 | Civil Cover Sheet (2) |
| Oct 25, 2019 | 2 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by CYNTHIA STENCEL BETZ on behalf of NOVARTIS PHARMACEUTICALS CORPORATION (BETZ, CYNTHIA) |
| Oct 25, 2019 | 3 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by NOVARTIS PHARMACEUTICALS CORPORATION identifying Novartis AG as Corporate Parent.. (FLAHERTY, JOHN) |
| Oct 25, 2019 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (abr) |
| Oct 25, 2019 | 5 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to MACLEODS PHARMA USA, INC., MACLEODS PHARMACEUTICALS LTD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (abr) |
| Oct 25, 2019 | 1 | Main Document (13) Docket Text: COMPLAINT against MACLEODS PHARMA USA, INC., MACLEODS PHARMACEUTICALS LTD. ( Filing and Admin fee $ 400 receipt number 0312-10060922), filed by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Statement of Corporate Disclosures, # (5) Civil Cover Sheet)(FLAHERTY, JOHN) |
| Oct 25, 2019 | 1 | Complaint* (1) |
